Malignant Solid Neoplasm Clinical Trials in Kansas City, Missouri

7 studies are recruiting for malignant solid neoplasm in Kansas City, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University Health Truman Medical Center, Kansas City, Missouri
    Locations
    52 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT03816345 on ClinicalTrials.gov

  2. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the earl…

    Stage
    Not phased
    Ages
    40 to 75
    Site
    Kansas City Veterans Affairs Medical Center, Kansas City, Missouri
    Locations
    745 in total
    Run by
    Alliance for Clinical Trials in Oncology

    See if you can join NCT05334069 on ClinicalTrials.gov

  3. The Vanguard Study: Testing a New Way to Screen for Cancer

    The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a need to understand h…

    Stage
    Not phased
    Ages
    45 to 75
    Site
    Saint Luke's Hospital of Kansas City, Kansas City, Missouri
    Locations
    44 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT06995898 on ClinicalTrials.gov

  4. Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

    This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with alkylating agents. Alkylating agents are part of standard chemotherapy, but may cause damage to the ovaries. I…

    Stage
    Phase 3
    Ages
    Up to 39
    Site
    Children's Mercy Hospitals and Clinics, Kansas City, Missouri
    Locations
    206 in total
    Run by
    Children's Oncology Group

    See if you can join NCT06513962 on ClinicalTrials.gov

  5. Project: Every Child for Younger Patients With Cancer

    This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

    Stage
    Not phased
    Ages
    Up to 25
    Site
    Children's Mercy Hospitals and Clinics, Kansas City, Missouri
    Locations
    279 in total
    Run by
    Children's Oncology Group

    See if you can join NCT02402244 on ClinicalTrials.gov

  6. Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

    This study examines how certain risk factors (such as age, gender, other medical conditions, and the type of immunotherapy used to treat the cancer) affect whether a patient with a malignant solid tumor will develop mild or serious side effects from the immunotherapy medications. Immunotherapy is t…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University Health Truman Medical Center, Kansas City, Missouri
    Locations
    849 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT04871542 on ClinicalTrials.gov

  7. A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

    This phase III single arm trial determines whether taking prophylactic letermovir will reduce the likelihood of infection with cytomegalovirus (CMV) in children and adolescents after stem cell transplant compared to estimated rate of infection without prophylaxis. The treatments used to prepare for…

    Stage
    Phase 3
    Ages
    2 to 18
    Site
    Children's Mercy Hospitals and Clinics, Kansas City, Missouri
    Locations
    29 in total
    Run by
    Children's Oncology Group

    See if you can join NCT05711667 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.